+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atrial Fibrillation Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatment, Non-Pharmacological Treatment), By End-use (Hospital, Specialty Clinics), By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 105 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5846809
Description Jump to:
The global atrial fibrillation market size is expected to reach USD 48.01 billion by 2030, registering at a CAGR of 10.1%, according to this report.Aging population, lifestyle changes, and chronic diseases such as diabetes and obesity are factors contributing to the increasing incidence of atrial fibrillation (AFib). The National Institute of Health reports that AFib affects 37.5 million people globally (0.51% of the population), a 33% increase in the past 20 years.

Moreover, with millions worldwide affected by AFib, and thousands of hospitalizations and deaths annually, there is a critical need for innovative therapies and solutions. In the U.S. alone, the CDC reports almost 454,000 hospitalizations with AFib as the primary diagnosis each year, resulting in over 158,000 deaths. These numbers highlight a significant market opportunity for companies to develop and market new products for diagnosing, treating, and managing atrial fibrillation.

Atrial fibrillation is commonly treated in emergency departments, but during the COVID-19 pandemic, there has been a decrease in admissions for primary diagnoses of AF compared to pre-pandemic times. Despite this, the article published by MDPI in 2021 states that up to 7.5% of COVID-19 patients may develop AF, which could increase the demand for AF treatments. However, other studies have reported a decrease in visits by patients with persistent and paroxysmal atrial fibrillation during the pandemic, due to changes in patient behavior, a decline in AF procedures, and disruptions to global supply chains causing shortages of certain medical devices and equipment.

Increasing government approvals and new product launches by key players are expected to drive growth in the atrial fibrillation products market. For instance, in March 2023, Medtronic received CE Mark approval for its Ablation System and Affera Mapping, which is designed to treat atrial arrhythmias using the Affera Prism-1 Mapping Software and Sphere-9 Catheter. This system integrates radiofrequency, pulsed field ablation, and high-density mapping catheter to provide real-time feedback and accurate mapping and ablation of abnormal heart rhythms, creating a new standard in electrophysiology.

Atrial Fibrillation Market Report Highlights

  • Based on treatment type, the AFib market is segmented into pharmacological and non-pharmacological treatment. Pharmacological treatment segment held the largest revenue share of over 65% of the atrial fibrillation market in 2022, due to the high demand for anticoagulant drugs and anti-arrhythmic drugs
  • Based on end-use, the market has been further categorized into hospitals, specialty clinics, and others. The hospitals segment accounted for the largest share of the market in 2022, and it is estimated to register the fastest CAGR of 10.4% during the forecast period. The segment's rapid growth is primarily attributed to the high number of surgeries performed in hospitals
  • The North American region is expected to dominate the market and held the largest revenue share of over 39% in 2022, owing to the increasing incidence of atrial fibrillation and a large patient population
  • Asia Pacific is estimated to grow at the fastest rate during the forecast period due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.5.1. Commodity Flow Analysis
1.5.1.1. Approach 1: Commodity flow approach
1.6. Data Validation & Publishing
1.7. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.5. Market Restraint Analysis
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.6.2. Porter’s Five Forces Analysis
3.7. COVID-19 Impact Analysis
Chapter 4. Treatment Type Business Analysis
4.1. Atrial Fibrillation Market, By Treatment Type: Key Takeaways
4.2. Atrial Fibrillation Market: Treatment Type Movement & Market Share Analysis, 2022 & 2030
4.3. Pharmacological Treatment
4.3.1. Global Pharmacological Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Anti-arrhythmic Drugs
4.3.2.1. Global Anti-arrhythmic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Anticoagulant Drugs
4.3.3.1. Global Anticoagulant Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Non-Pharmacological Treatment
4.4.1. Global Non-Pharmacological Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Catheter Ablation
4.4.2.1. Global Catheter Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.2. Radiofrequency
4.4.2.2.1. Global Radiofrequency Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.3. HIFU
4.4.2.3.1. Global HIFU Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.4. Cryoablation
4.4.2.4.1. Global Cryoablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.5. Microwave
4.4.2.5.1. Global Microwave Market Estimates and Forecasts, 2018 - 2030 (USD Million
4.4.2.6. Laser
4.4.2.6.1. Global Laser Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Maze Surgery
4.4.3.1. Global Maze Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Electric Cardioversion
4.4.4.1. Global Electric Cardioversion Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. End-Use Business Analysis
5.1. Atrial Fibrillation Market, By End-Use: Key Takeaways
5.2. Atrial Fibrillation Market: End-Use Movement & Market Share Analysis, 2022 & 2030
5.3. Hospitals
5.3.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Specialty Clinics
5.4.1. Global Specialty Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Regional Market Snapshot
6.2. Market Share Analysis by Region, 2022
6.3. North America
6.3.1. North America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. U.S. Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Canada Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Europe Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Germany Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.4.3. UK
6.4.3.1. UK Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. France Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Italy Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Spain Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.4.7. Denmark
6.4.7.1. Denmark Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.4.8. Sweden
6.4.8.1. Sweden Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.4.9. Norway
6.4.9.1. Norway Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Japan Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.5.3. China
6.5.3.1. China Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. India Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. South Korea Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.5.6. Australia
6.5.6.1. Australia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.5.7. Thailand
6.5.7.1. Thailand Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Latin America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Brazil Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.6.3. Mexico
6.6.3.1. Mexico Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.6.4. Argentina
6.6.4.1. Argentina Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. MEA Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.7.2. South Africa
6.7.2.1. South Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. UAE Atrial Fibrillation Market, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Kuwait Atrial Fibrillation Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Profiles/Listing
7.3.1. AtriCure Inc.
7.3.1.1. Overview
7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.1.3. Product Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Boehringer Ingelheim GmbH
7.3.2.1. Overview
7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.2.3. Product Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Boston Scientific Corporation.
7.3.3.1. Overview
7.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.3.3. Product Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. Bristol- Myers Squibb Corporation
7.3.4.1. Overview
7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.4.3. Product Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Cardio Focus Inc.
7.3.5.1. Overview
7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.5.3. Product Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Sanofi Aventis
7.3.6.1. Overview
7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.6.3. Product Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Biosense Webster Inc.
7.3.7.1. Overview
7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.7.3. Product Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Endoscopic Technologies Inc.
7.3.8.1. Overview
7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.8.3. Product Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Abbott (St. Jude Medical Inc.)
7.3.9.1. Overview
7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.9.3. Product Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. Johnsons & Johnson
7.3.10.1. Overview
7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.10.3. Product Benchmarking
7.3.10.4. Strategic Initiatives
List of Tables
Table 1: List of Abbreviations
Table 2: Global Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 3: Global Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 4: Global Atrial Fibrillation Market, by region, 2018-2030 (USD Million)
Table 5: North America Atrial Fibrillation Market, by country, 2018-2030 (USD Million)
Table 6: North America Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 7: North America Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 8: U.S. Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 9: U.S. Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 10: Canada Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 11: Canada Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 12: Europe Atrial Fibrillation Market, by country, 2018-2030 (USD Million)
Table 13: Europe Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 14: Europe Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 15: Germany Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 16: Germany Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 17: UK Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 18: UK Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 19: France Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 20: France Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 21: Italy Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 22: Italy Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 23: Spain Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 24: Spain Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 25: Denmark Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 26: Denmark Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 27: Sweden Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 28: Sweden Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 29: Norway Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 30: Norway Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 31: Asia Pacific Atrial Fibrillation Market, by country, 2018-2030 (USD Million)
Table 32: Asia Pacific Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 33: Asia Pacific Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 34: China Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 35: China Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 36: Japan Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 37: Japan Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 38: India Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 39: India Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 40: South Korea Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 41: South Korea Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 42: Australia Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 43: Australia Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 44: Thailand Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 45: Thailand Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 46: Latin America Atrial Fibrillation Market, by country, 2018-2030 (USD Million)
Table 47: Latin America Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 48: Latin America Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 49: Brazil Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 50: Brazil Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 51: Mexico Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 52: Mexico Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 53: Argentina Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 54: Argentina Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 55: Middle East & Africa Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 56: Middle East & Africa Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 57: South Africa Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 58: South Africa Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 59: Saudi Arabia Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 60: Saudi Arabia Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 61: UAE Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 62: UAE Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
Table 63: Kuwait Atrial Fibrillation Market, by treatment type, 2018-2030 (USD Million)
Table 64: Kuwait Atrial Fibrillation Market, by end-use, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information procurement
Fig. 3: Primary research pattern
Fig. 4: Market research approaches
Fig. 5: Value chain-based sizing & forecasting
Fig. 6: Market formulation & validation
Fig. 7: Atrial Fibrillation Market segmentation
Fig. 8: Market snapshot, 2022
Fig. 9: Market trends & outlook
Fig. 10: Market driver relevance analysis (current & future impact)
Fig. 11: Market restraint relevance analysis (current & future impact)
Fig. 12: Swot analysis, by factor (political & legal, economic and technological)
Fig. 13: Porter’s five forces analysis
Fig. 14: Market penetration & growth prospect mapping, 2022
Fig. 15: Global Atrial Fibrillation Market: treatment type outlook key takeaways
Fig. 16: Global Atrial Fibrillation Market: treatment type movement analysis
Fig. 17: Pharmacological Treatment market, 2018-2030 (USD Million)
Fig. 18: Anti-arrhythmic Drugs market, 2018-2030 (USD Million)
Fig. 19: Anticoagulant Drugs market, 2018-2030 (USD Million)
Fig. 20: Non-Pharmacological Treatment market, 2018-2030 (USD Million)
Fig. 21: Catheter Ablation market, 2018-2030 (USD Million)
Fig. 22: Radiofrequency market, 2018-2030 (USD Million)
Fig. 23: HIFU market, 2018-2030 (USD Million)
Fig. 24: Cryoablation market, 2018-2030 (USD Million)
Fig. 25: Microwave market, 2018-2030 (USD Million)
Fig. 26: Laser market, 2018-2030 (USD Million)
Fig. 27: Maze Surgery market, 2018-2030 (USD Million)
Fig. 28: Electric Cardioversion market, 2018-2030 (USD Million)
Fig. 29: Global Atrial Fibrillation Market: end-use outlook key takeaways
Fig. 30: Global Atrial Fibrillation Market: end-use movement analysis
Fig. 31: Global Hospital market, 2018-2030 (USD Million)
Fig. 32: Global Specialty Clinics market, 2018-2030 (USD Million)
Fig. 33: Global others market, 2018-2030 (USD Million)
Fig. 34: Regional marketplace: key takeaways
Fig. 35: Regional outlook, 2022 & 2030
Fig. 36: Global Atrial Fibrillation Market: region movement analysis
Fig. 37: North America Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 38: U.S. Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 39: Canada Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 40: Europe Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 41: Germany Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 42: UK Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 43: France Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 44: Italy Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 45: Spain Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 46: Denmark Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 47: Sweden Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 48: Norway Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 49: Asia pacific Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 50: Japan Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 51: China Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 52: India Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 53: Australia Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 54: South Korea Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 55: Thailand Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 56: Latin America Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 57: Brazil Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 58: Mexico Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 59: Argentina Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 60: Middle East and Africa Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 61: South Africa Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 62: Saudi Arabia Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 63: UAE Atrial Fibrillation Market, 2018-2030 (USD Million)
Fig. 64: Kuwait Atrial Fibrillation Market, 2018-2030 (USD Million)

Companies Mentioned

  • AtriCure Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation.
  • Bristol- Myers Squibb Corporation
  • Cardio Focus Inc.
  • Sanofi Aventis
  • Biosense Webster Inc.
  • Endoscopic Technologies Inc.
  • Abbott (St. Jude Medical Inc.)
  • Johnsons & Johnson

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages105
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 22.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 48.01 Billion
Compound Annual Growth Rate10.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Atrial Fibrillation Global Market Report 2024 - Product Image

Atrial Fibrillation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Atrial Fibrillation Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Atrial Fibrillation Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 181 Pages
  • Global
From
Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 145 Pages
  • Global
From
Global Atrial Fibrillation Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Atrial Fibrillation Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 179 Pages
  • Global
From
Atrial Fibrillation Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Atrial Fibrillation Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 90 Pages
  • Global
From

About the Atrial Fibrillation Market

Atrial Fibrillation (AF) is a common cardiac arrhythmia that affects millions of people worldwide. It is characterized by an irregular and rapid heart rate, which can lead to a variety of symptoms, including palpitations, shortness of breath, and fatigue. AF can also increase the risk of stroke and other cardiovascular complications. Treatment options for AF include lifestyle modifications, medications, and catheter ablation. The AF market is a rapidly growing segment of the cardiology industry. It is driven by an aging population, increasing prevalence of AF, and the development of new technologies and treatments. The market is expected to continue to grow in the coming years, driven by the increasing demand for better diagnosis and treatment of AF. Some of the major companies in the AF market include Medtronic, Boston Scientific, Abbott, Biosense Webster, and St. Jude Medical. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.